Nanocapsules Market Size & Trends
- Reports Overview
- Table Of Content
- Research Methodology
Nanocapsules Market Size & Trends The global nanocapsules market size was valued at USD 3.43 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030.
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information
or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation &
Publishing
1.4.
Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive
Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Nanocapsules Market Variables, Trends,
& Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market
Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Nanocapsules Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1.
Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3.
Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive
rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and
Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental
landscape
3.4.2.5. Legal landscape
Chapter 4. Nanocapsules Market: Application
Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Nanocapsules Market: Application Movement Analysis, 2023 & 2030
(USD Million)
4.3.
Healthcare
4.3.1. Healthcare Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
4.4. Food
& Nutraceuticals
4.4.1. Food & Nutraceuticals Market Revenue Estimates and Forecasts, 2018 – 2030
(USD Million)
4.5.
Cosmetics
4.5.1. Cosmetics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
4.6.
Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
Chapter 5. Nanocapsules Market: Therapeutic Area Estimates & Trend
Analysis
5.1. Segment Dashboard
5.2. Nanocapsules Market: Therapeutic Area Movement Analysis, 2023 & 2030 (USD
Million)
5.3.
Oncology
5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
5.4. Pain
Management
5.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
5.5.
Endocrinology
5.5.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
5.6.
Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD
Million)
Chapter 6. Nanocapsules Market: Regional Estimates & Trend
Analysis
6.1. Nanocapsules Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North
America Nanocapsules Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Nanocapsules Market Estimates and Forecasts, 2018 – 2030 (USD
Million)
6.2.3. Canada
6.2.3.1. Canada Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3. Europe
6.3.1. Europe Nanocapsules Market Estimates and Forecasts, 2018 – 2030 (USD
Million)
6.3.2. U.K.
6.3.2.1. U.K. Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Nanocapsules Market Estimates and Forecasts, 2018
– 2030 (USD Million)
6.3.4. France
6.3.4.1. France Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Nanocapsules Market Estimates and Forecasts, 2018
– 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.3.9. Norway
6.3.9.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.4.3. China
6.4.3.1. China Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.4.4. India
6.4.4.1. India Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Nanocapsules Market Estimates and
Forecasts, 2018 – 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Thailand Nanocapsules Market
Estimates and Forecasts, 2018 – 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Nanocapsules Market Estimates
and Forecasts, 2018 – 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Nanocapsules Market Estimates
and Forecasts, 2018 – 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Nanocapsules Market
Estimates and Forecasts, 2018 – 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Nanocapsules
Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South
Africa Nanocapsules Market Estimates and Forecasts, 2018 – 2030 (USD Million)
6.6.3. Saudi
Arabia
6.6.3.1. Saudi Arabia Nanocapsules Market Estimates and Forecasts, 2018 – 2030 (USD
Million)
6.6.4. UAE
6.6.4.1. UAE Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Nanocapsules Market Estimates and Forecasts, 2018 –
2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis
by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. BioDelivery Sciences
7.4.1.1.
Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product
Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Camurus
7.4.2.1.
Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product
Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Carlina
Technologies
7.4.3.1. Participant’s Overview
7.4.3.2. Financial
Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic
Initiatives
7.4.4. Cerulean Pharma Inc.
7.4.4.1. Participant’s Overview
7.4.4.2.
Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/
Strategic Initiatives
7.4.5. Nano Green Sciences, Inc.
7.4.5.1. Participant’s
Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. NanoNutra
7.4.6.1.
Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product
Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. NanoSphere Health
Science
7.4.7.1. Participant’s Overview
7.4.7.2. Financial
Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic
Initiatives
7.4.8. Eos Biosciences, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2.
Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/
Strategic Initiatives
7.4.9. PolyMicrospheres
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4.
Recent Developments/ Strategic Initiatives
7.4.10. GAT Food Essentials
7.4.10.1. Participant’s
Overview
7.4.10.2. Financial Performance
7.4.10.3. Product
Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
Research Methodology
Grand View Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation that looks market from three different perspectives. Critical elements of methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
• Market drivers and restrains, along with their current
and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and
expected capacity additions up to 2030
We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.
Primary validation
This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:
• Market leading companies
• Raw
material suppliers
• Product distributors
• Buyers
The key objectives of primary research are as follows:
• To validate our data in terms of accuracy and
acceptability
• To gain an insight in to the current market and future
expectations
Data Collection Matrix
|
Perspective |
Primary research |
Secondary research |
|
Supply side |
|
|
|
Demand side |
|
|
Industry Analysis
Matrix
|
Qualitative analysis |
Quantitative analysis |
|
|
Nanocapsules are used in the pharmaceutical and food industries. They are increasingly used in drug delivery systems and as encapsulation agents in the food industry due to their ability to improve bioavailability, stability, and controlled release of active ingredients. Chronic disease incidences have been increasing worldwide, and there arises the need for an effective and new drug delivery system that can deliver the required quantity of drugs to the site of action at a specific time. Nanocapsules act as an alternative to conventional treatments and help in targeted delivery and can be used in distinct applications such as biosensors or in medical imaging, helping in cancer detection.
The research and innovation by the top key players are driving the adoption of advanced technologies and innovation techniques, thus benefiting market growth. There has been a significant demand for personalized and innovative products in the cosmetic industry and cosmetic companies are adopting nanotechnologies to develop such products. Nanocarriers help in improving the poor stability, solubility penetration and uncontrolled release of cosmetic active ingredients. The manufacturing companies are utilizing such developed techniques, and the increasing awareness among people has driven the demand in the market.
The increasing proportion of the aging population and the globalization of unhealthy lifestyles have led to the increased prevalence of chronic diseases worldwide. This has led market players to develop advanced medical techniques and innovations to treat chronic diseases, which is likely to surge the demand for nanocapsule-based products. In addition, international organizations are also taking initiatives to reduce the risk of chronic diseases. For instance, WHO has aimed to reduce premature mortality from chronic diseases by one-third through prevention and treatment by the year 2030. Such initiatives are also expected to add to market growth.
Application Insights & Trends
“Healthcare segment is expected to witness growth at 5.5% CAGR.”
Healthcare dominated the market and accounted for a share of 63.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period. This high share is attributed to medical advances made in medicine in various functionalities such as gene therapy, drug delivery, medical imaging nanobots, and others. Nanocapsules are used in gene therapy as delivery vectors to transfer genetic materials efficiently into cells. It is designed to protect and condense nucleic acids such as DNA & RNA and facilitate their cytosolic delivery, thereby enhancing gene expression. For instance- in 2021, research was performed on chitosan (CS)-based NCs, which proved to have enormous potential for the treatment of genetic lung diseases. These nanocapsules are designed to encapsulate genetic material, such as the pCMV-βGal gene, and are microencapsulated in Ma microspheres (MS) for targeted delivery to the lungs.
Nanocapsules have been investigated for the delivery of anti-inflammatory drugs, anti-cancer drugs, and agents for immunotherapy. Their small size and ability to cross biological barriers make them well-suited for these applications. It can be used as part of MRI-guided nanorobotic systems for therapeutic and diagnostic applications. The concept involves using an MRI scanner to induce the required driving forces to control and direct the movement of magnetic NCs to targeted areas of the body. These vast applications of NCs in the healthcare sector have driven the market to grow.
Food & nutraceuticals segment is expected to register significant CAGR during the forecast period. It is attributed due to its application in food processing, nanoscale nutraceutical delivery systems, nanoemulsions and colloids, nanoscale rapid detection devices for contaminants, nanofiltration, and nanocomposite packaging materials. The surge in usage of nanocapsules in such applications has led this segment to grow at a faster rate, thereby impacting the market positively. For instance, according to the research study published in the National Library of Medicine in 2023, researchers synthesized Ag and TiO2 nanoparticles with excellent dielectric properties and structural and electrical conductivity combing hydrogels and aerogels to improve the antibacterial effect and mechanical properties of the polymer blend (Cs/PEO). This confirmed the potential use of these materials in the food packaging industry. The surge in such usage of nanocapsules has led this segment to grow at a faster rate, thereby driving the market to grow in the forecast period.
Therapeutic Area Insights & Trends
“The oncology segment is expected to grow at a CAGR of 6.4%.”
Oncology accounted for the largest market revenue share in 2023. Nanocapsules have emerged as a promising tool in oncology, offering several benefits in cancer therapy and diagnosis. These vesicular systems, characterized by a core-shell structure, can be engineered to incorporate various chemotherapeutic or diagnostic agents. The delivery systems based on nanocapsules are designed to target tumors and release their contents upon environmental changes, enhancing the efficacy of treatment and reducing side effects on healthy tissue. According to WHO, an estimated 20 million new cancer cases and 9.7 million deaths occurred in 2022 worldwide.
The increasing cases of cancer have led researchers to work on developing new drugs and methods to control the incidence rates, thereby introducing novel methods to counter its effects. For instance, in 2023, research was conducted for efficient tumor eradication at ultralow drug concentration via externally controlled and boosted metallic iron magneto plasmonic NCs. For instance, in 2022, a nanocapsule in which Perfluorooctyl Bromide (PFOB) was encapsulated that makes several key improvements was invented that has the potential applications for image guided cancer treatments.
Pain management is expected to register the fastest CAGR over the forecast period. Nanocapsules have been explored as a promising approach to pain management due to their unique properties and potential to improve the efficacy and safety of analgesic treatments. Polymeric nanoparticles and influential carriers such as silica, gold, and magnetic nanoparticles have been investigated for pain modulation. Liposomes are the primary drug delivery system used to deliver local anesthetic drugs for skin analgesia and management of post-surgical pain. For instance, in 2022, research was conducted for local anesthetics and pain management where NCs were synthesized with blended polymeric hydrogel loaded with bupivacaine drug delivery system.
Regional Insights & Trends
“Canada to witness market growth of CAGR 7.0%.”
North America nanocapsule market dominated market with the revenue share of 24.5% in 2023. It is attributable to rising incidences of chronic diseases in the region, which has led to an increased demand for investments in R&D in North American countries and intensified the efforts to develop novel and improved therapies. For instance, about 45.1% of Canadians were reported to have at least one major chronic disease in 2021. Various government initiatives and the establishment of research institutes have encouraged the application of nanocapsules in treating various diseases.
U.S. Nanocapsules Market Trends
The U.S. nanocapsules market dominated in 2023 and accounted for a market share of 34.4% due to a rise in the number of chronic diseases, government initiatives, and high-scale investments in R&D. According to a report in 2024, an estimated 129 million people in the U.S. suffer from at least one major chronic disease in a lifetime. National Nanotechnology Initiative works to advance discovery and innovation across the entire nanotechnology R&D enterprise across the U.S. The President’s 2023 Budget requested USD 1.99 billion for the NNI, with investments in foundational research fueling new discoveries and application-driven research.
Europe Nanocapsules Market Trends
Europe nanocapsules market was identified as a lucrative region in this industry. This is attributed to the increasing funding and investments in nanotechnology-based research in developed countries of this region. For instance, The Phoenix Project funded by the European Union’s Horizon 2020 Framework Programme ensures that nano pharmaceuticals can be developed and deployed effectively from the laboratory to the market. The rise in chronic diseases such as cardiovascular diseases, cancer, and diabetes has also created space for advanced research work for the treatment.
Asia Pacific Nanocapsules Market Trends
The Asia Pacific region is anticipated to witness significant growth in the Nanocapsules market. This is attributed to the increasing opportunities in nanotechnology-based research and development. China, Japan, South Korea, Singapore, and India are leading the way in promoting the application of nanocapsules in treating diseases. Japan, being an advanced country, is credited with employing NCs in various functionalities. For instance, in 2023, researchers at Tokyo Institute of Technology developed a nano capsulation strategy for facile analysis and processing of insoluble aromatic polymers in water. China and India are conducting research activities and various conferences and events addressing the need for the development of novel improved therapy potential and to drive the market in the forecast period.
Key Nanocapsules Company Insights
Some of the key companies in the nanocapsules market include BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma Inc., Nano Green Sciences, Inc., and NanoNutra. Key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies.
- Carlina Technologies is a France-based biopharmaceutical company that specializes in developing nanomedicine. It uses advanced non-denaturing drug delivery technologies for therapeutic proteins, peptides, and other drugs.
- Eos Biosciences, Inc. is a biotargeting nanomedicine company based in the U.S. The company holds exclusive worldwide rights to the novel and innovative drug targeting and drug delivery platform technologies, enabling the effective delivery of approved novel therapeutics to disease sites with improved efficacy and safety profiles of the therapeutic payload, providing a platform approach that can be easily applied to many diseases and has many therapeutic applications.
Key Nanocapsules Companies:
The following are the leading companies in the nanocapsulesmarket. These companies collectively hold the largest market share and dictate industry trends.
- BioDelivery Sciences
- Camurus
- Carlina Technologies
- Cerulean Pharma Inc.
- Nano Green Sciences, Inc.
- NanoNutra
- NanoSphere Health Science
- Eos Biosciences, Inc.
- PolyMicrospheres
- GAT Food Essentials
Recent Developments
- In May 2024, Camurus received EMA acceptance of CAM2029 (MAA filing for octreotide SC depot) for the treatment of acromegaly. It is a significant milestone in the development of this nanocapsules-based medicine.
- In May 2019, NanoSphere Health Sciences and Stat Shield Technology launched evolve products for veterans through a strategic partnership. This partnership is expected to help in increasing their access to advanced technology and treatment.
Nanocapsules Market Report Scope
| Report Attribute | Details |
| Market size value in 2024 | USD 3.57 billion |
| Revenue forecast in 2030 | USD 4.89 billion |
| Growth Rate | CAGR of 5.4% from 2024 to 2030 |
| Base year for estimation | 2023 |
| Historical data | 2018 – 2022 |
| Forecast period | 2024 – 2030 |
| Report updated | August 2024 |
| Quantitative units | Revenue in USD million and CAGR from 2024 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Application, Therapeutic Area, Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
| Country scope | U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway Germany, UK, France, Japan, China, India, Australia, South Korea, Thailand, China, Japan, India, Australia, Brazil, Argentina, KSA, UAE, and South Africa, South Arabia, Kuwait |
| Key companies profiled | BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma Inc., Nano Green Sciences, Inc., NanoNutra, NanoSphere Health Science, Eos Biosciences, Inc., PolyMicrospheres, GAT Food Essentials |
| Customization scope | Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Global Nanocapsules Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nanocapsules market report based on application, therapeutic area and region.
Application Outlook (Revenue, USD Million; 2018 – 2030)
Kuwait
Healthcare
Food & Nutraceuticals
Cosmetics
Others
Therapeutic Area Outlook (Revenue, USD Million; 2018 – 2030)
Oncology
Pain Management
Endocrinology
Others
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get A SampleRegional Outlook (Revenue, USD Million; 2018 – 2030
| Region | Countries |
|---|---|
| North America | U.S. Canada Mexico |
| Europe | UK, Germany, France, Italy, Spain, Denmark ,Sweden, Norway, Kuwait |
| APAC | Japan, China, India, Australia, South Korea, Thailand |
| Latin America | Brazil, Argentina |
| MEA | South Africa, Saudi Arabia, UAE |
